You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Emtricitabine (FTC)/tenofovir alafenamide (TAF)

Showing 1 - 25 of 1,047
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Infection Trial (dolutegravir (DTG)/emtricitabine (FTC)/tenofovir alafenamide (TAF) regimen)

Not yet recruiting
  • HIV Infection
  • dolutegravir (DTG)/emtricitabine (FTC)/tenofovir alafenamide (TAF) regimen
  • (no location specified)
Aug 8, 2023

HIV, Renal Transplant Rejection Trial in New York (BIKTARVY 50Mg-200Mg-25Mg Tablet)

Recruiting
  • HIV Infections
  • Renal Transplant Rejection
  • BIKTARVY 50Mg-200Mg-25Mg Tablet
  • New York, New York
    Weill Cornell Medicine
Aug 1, 2022

HIV-1 Infection Trial (DOR/ISL, BIC/FTC/TAF, Placebo to BIC/FTC/TAF)

Not yet recruiting
  • HIV-1 Infection
  • (no location specified)
Dec 19, 2022

HIV Trial in Houston (B/FTC/TAF, Current ART)

Terminated
Has Results
  • HIV Infections
  • Houston, Texas
    Thomas Street Health Center
Sep 1, 2022

HIV Trial (DTG/3TC)

Not yet recruiting
  • HIV
  • (no location specified)
Jun 9, 2023

Bictegravir in the Elderly Living With HIV (BICEP)

Active, not recruiting
  • HIV-1-infection
  • Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
  • Buffalo, New York
    Evergreen Health
Oct 28, 2022

Healthy Trial (JNJ-56136379, Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF))

Withdrawn
  • Healthy
  • JNJ-56136379
  • Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF)
  • (no location specified)
Jul 12, 2021

HIV Trial in Canada (PrEP, mHealth Model of Care, Standard of Care)

Not yet recruiting
  • HIV Infections
  • Calgary, Alberta, Canada
  • +4 more
Dec 6, 2021

HIV Primary Infection Trial in Barcelona (50mg bictegravir/200mg emtricitabine/25mg tenofovir alafenamide)

Recruiting
  • HIV Primary Infection
  • 50mg bictegravir/200mg emtricitabine/25mg tenofovir alafenamide
  • Barcelona, Spain
    Hospital Clinic
Jul 16, 2021

HIV, Fatty Liver Disease Trial in Madrid (Dolutegravir (DTG) 50 mg/day + Rilpivirine (RPV) 25mg per day, Tenofovir disoproxil

Recruiting
  • HIV Infections
  • Fatty Liver Disease
  • Dolutegravir (DTG) 50 mg/day + Rilpivirine (RPV) 25mg per day
  • +2 more
  • Madrid, Spain
  • +3 more
Jun 13, 2023

Human Immunodeficiency Virus Type 1 Trial in Worldwide (D/C/F/TAF, Boosted Protease Inhibitor (bPI), FTC/TDF)

Completed
Has Results
  • Human Immunodeficiency Virus Type 1
  • Phoenix, Arizona
  • +81 more
Nov 25, 2021

Hiv, Hormone Therapy Trial in San Diego (Emtricitabine / Tenofovir Disoproxil Oral Tablet 200/300 mg, Emtricitabine Tenofovir

Completed
  • Hiv
  • Hormone Therapy
  • Emtricitabine / Tenofovir Disoproxil Oral Tablet 200/300 mg
  • Emtricitabine Tenofovir Alafenamide 200/25 mg
  • San Diego, California
    UC San Diego AntiViral Research Center (AVRC)
Sep 21, 2022

Medication Adherence, HIV Trial in Pittsburgh (dolutegravir oral tablet 50mg, emtricitabine/tenofovir alafenamide oral tablet

Completed
  • Medication Adherence
  • HIV
  • dolutegravir oral tablet 50mg
  • +3 more
  • Pittsburgh, Pennsylvania
    HIV/AIDS Clinical Research Unit / University of Pittsburgh
Mar 2, 2022

HIV, HIV Trial (Dolutegravir, Lamivudine, Bictegravir)

Not yet recruiting
  • HIV
  • HIV Infections
  • (no location specified)
Aug 4, 2023

Human Immunodeficiency Virus Trial in Oakland Park (bictegravir/emtricitabine/tenofovir alafenamide)

Completed
  • Human Immunodeficiency Virus
  • bictegravir/emtricitabine/tenofovir alafenamide
  • Oakland Park, Florida
    Midland Research Group, Inc
Feb 23, 2021

Hiv Trial in Cape Town (Tenofovir alafenamide, Tenofovir Disoproxil Fumarate)

Recruiting
  • Hiv
  • Tenofovir alafenamide
  • Tenofovir Disoproxil Fumarate
  • Cape Town, South Africa
    Gugulethu Midwife Obstetric Unit
Nov 1, 2022

HIV Trial in Toronto (drug, behavioral, other)

Recruiting
  • HIV Infections
  • Toronto, Ontario, Canada
  • +2 more
Nov 19, 2021

HIV-1-infection Trial in Edmonton (B/F/TAF, Atripla, B/F/TAF Placebo)

Terminated
Has Results
  • HIV-1-infection
  • Edmonton, Alberta, Canada
    University of Alberta
Nov 21, 2022

Abacavir and Lamivudine Anabolites

Completed
  • HIV-1-infection
  • Blood collection
  • +3 more
  • Aurora, Colorado
    University of Colorado Hospital
Jan 5, 2023

HIV-1 Trial in Panama, South Africa, United States (F/TAF, 3rd ARV agent, Boosted PIs)

Active, not recruiting
Has Results
  • HIV-1
  • Los Angeles, California
  • +7 more
Nov 11, 2022

Drug Interaction Trial in Bangkok (Emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (F/TDF) and emtricitabine 200

Recruiting
  • Drug Interaction
  • Emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (F/TDF) and emtricitabine 200 mg/tenofovir alafenamide 25 mg (F/TAF)
  • Bangkok, Pathumwan, Thailand
    Institute of HIV Research and Innovation (IHRI)
Apr 21, 2022

HIV I Infection Trial in Orlando (Dolutegravir / Lamivudine Pill, Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill)

Active, not recruiting
  • HIV I Infection
  • Dolutegravir / Lamivudine Pill
  • Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill
  • Orlando, Florida
    Orlando Immunology Center
Sep 20, 2022

Osteoporosis, HIV, Menopause Trial in Canada, Italy (tenofovir-alafenamide-emtricitabine, tenofovir-emtricitabine)

Completed
Has Results
  • Osteoporosis
  • +2 more
  • Vancouver, British Columbia, Canada
  • +6 more
Dec 22, 2022

Acceptability of Health Care, Adherence, Medication Trial in Durban, Pietermaritzburg, Harare (emtricitabine/tenofovir

Recruiting
  • Acceptability of Health Care
  • Adherence, Medication
  • emtricitabine/tenofovir alafenamide
  • Emtricitabine / Tenofovir Disoproxil Oral Tablet
  • Durban, KZN, South Africa
  • +2 more
Jul 12, 2022

HIV-1-infection Trial in Shanghai, Kunming, Hangzhou (B/F/TAF, TDF-based triple ART regimen switching to B/F/TAF)

Recruiting
  • HIV-1-infection
  • B/F/TAF
  • TDF-based triple ART regimen switching to B/F/TAF
  • Shanghai, Shanghai, China
  • +2 more
Dec 1, 2022